Eli Lilly and Company v Canada - Second Notice of Intent - 13 June 2013
Country
Year
2013
Summary
On June 13, 2013, Eli Lily and Company, a US-based corporation, served the Government of Canada with a second Notice of Intent to Submit a Claim to Arbitration under NAFTA Chapter 11. Eli Lilly and Company is alleging that the invalidation of its Strattera and Zyprexa pharmaceutical patents by Canada is inconsistent with Canada’s commitments under NAFTA.